Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Authors' reply.

Ballantyne CM, Bays HE, Braeckman RA, Soni PN.

Am J Cardiol. 2013 Feb 1;111(3):455-6. doi: 10.1016/j.amjcard.2012.11.036. No abstract available.

PMID:
23317532
[PubMed - indexed for MEDLINE]
2.

ANCHOR trial conclusions regarding the effects of pure eicosapentaenoic acid on low-density lipoprotein cholesterol.

Baum SJ.

Am J Cardiol. 2013 Feb 1;111(3):454-5. doi: 10.1016/j.amjcard.2012.11.035. No abstract available.

PMID:
23317530
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study).

Ballantyne CM, Bays HE, Kastelein JJ, Stein E, Isaacsohn JL, Braeckman RA, Soni PN.

Am J Cardiol. 2012 Oct 1;110(7):984-92. doi: 10.1016/j.amjcard.2012.05.031. Epub 2012 Jul 20.

PMID:
22819432
[PubMed - indexed for MEDLINE]
4.

High-density lipoprotein cholesterol and triglycerides in the statin era: a pending issue?

Paillard F.

Arch Cardiovasc Dis. 2009 Mar;102(3):165-7. doi: 10.1016/j.acvd.2008.12.001. Epub 2009 Feb 23. No abstract available.

PMID:
19375669
[PubMed - indexed for MEDLINE]
Free Article
5.

Drugs for hypertriglyceridemia.

[No authors listed]

Med Lett Drugs Ther. 2013 Mar 4;55(1411):17-9. No abstract available.

PMID:
23467119
[PubMed - indexed for MEDLINE]
6.

Assessing the clinical benefits of lipid-disorder drugs.

Hiatt WR, Smith RJ.

N Engl J Med. 2014 Jan 30;370(5):396-9. doi: 10.1056/NEJMp1313866. No abstract available.

PMID:
24476429
[PubMed - indexed for MEDLINE]
Free Article
7.

First-line therapies for lowering triglyceride levels.

Raghavan VA.

Am Fam Physician. 2008 Feb 15;77(4):416; author reply 417-8. No abstract available.

PMID:
18326158
[PubMed - indexed for MEDLINE]
Free Article
8.

Role of fibrates in the management of hypertriglyceridemia.

Rader DJ, Haffner SM.

Am J Cardiol. 1999 May 13;83(9B):30F-35F. Review.

PMID:
10357573
[PubMed - indexed for MEDLINE]
9.

Triglycerides: a case for treatment?

Wierzbicki AS, Clarke RE, Viljoen A, Mikhailidis DP.

Curr Opin Cardiol. 2012 Jul;27(4):398-404. doi: 10.1097/HCO.0b013e328353adc1. Review.

PMID:
22565137
[PubMed - indexed for MEDLINE]
10.

Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.

Rosenson RS, Pitt B.

Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):98-100. doi: 10.1038/ncpcardio1435. Epub 2008 Dec 17. No abstract available.

PMID:
19079366
[PubMed - indexed for MEDLINE]
11.

Refining the American guidelines for prevention of cardiovascular disease - Authors' reply.

Ridker PM, Cook NR.

Lancet. 2014 Feb 15;383(9917):600. doi: 10.1016/S0140-6736(14)60216-6. No abstract available.

PMID:
24529467
[PubMed - indexed for MEDLINE]
12.

Clinical practice. Hypertriglyceridemia.

Brunzell JD.

N Engl J Med. 2007 Sep 6;357(10):1009-17. Review. No abstract available.

PMID:
17804845
[PubMed - indexed for MEDLINE]
13.

The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial: to believe or not to believe?

Nicholls SJ.

J Am Coll Cardiol. 2012 Jun 5;59(23):2065-7. doi: 10.1016/j.jacc.2012.02.021. Epub 2012 Apr 18. No abstract available.

PMID:
22520248
[PubMed - indexed for MEDLINE]
Free Article
14.

Understand how some medications can lower your triglycerides.

[No authors listed]

Heart Advis. 2010 Jul;13(7):7. No abstract available.

PMID:
23091865
[PubMed - indexed for MEDLINE]
15.

Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).

Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN.

Am J Cardiol. 2011 Sep 1;108(5):682-90. doi: 10.1016/j.amjcard.2011.04.015. Epub 2011 Jun 16.

PMID:
21683321
[PubMed - indexed for MEDLINE]
16.

Bridging the gap in treatment options for patients with hypertriglyceridemia.

Underberg JA, Hays R.

J Fam Pract. 2007 Dec;56(12 Suppl New):S24-31. Review.

PMID:
18664339
[PubMed - indexed for MEDLINE]
17.

A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients.

Chan WB, Ko GT, Yeung VT, Osaki R, Ma RC, So WY, Chow CC.

Diabetes Res Clin Pract. 2004 Oct;66(1):97-9. No abstract available.

PMID:
15364167
[PubMed - indexed for MEDLINE]
18.

Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.

Ryan AS, Keske MA, Hoffman JP, Nelson EB.

Am J Ther. 2009 Mar-Apr;16(2):183-92. doi: 10.1097/MJT.0b013e31817fe2be. Review.

PMID:
19145206
[PubMed - indexed for MEDLINE]
19.

Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia.

Nakamura N, Hamazaki T, Ohta M, Okuda K, Urakaze M, Sawazaki S, Yamazaki K, Satoh A, Temaru R, Ishikura Y, Takata M, Kishida M, Kobayashi M.

Int J Clin Lab Res. 1999;29(1):22-5.

PMID:
10356659
[PubMed - indexed for MEDLINE]
20.

Statin and exercise prescription - Authors' reply.

Kokkinos P, Faselis C, Myers J, Panagiotakos D, Doumas M.

Lancet. 2013 May 11;381(9878):1622-3. doi: 10.1016/S0140-6736(13)61018-1. No abstract available.

PMID:
23663943
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk